A detailed history of Cohen Investment Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cohen Investment Advisors LLC holds 7,619 shares of BMY stock, worth $378,969. This represents 0.21% of its overall portfolio holdings.

Number of Shares
7,619
Previous 7,132 6.83%
Holding current value
$378,969
Previous $386,000 18.13%
% of portfolio
0.21%
Previous 0.25%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$40.25 - $52.99 $19,601 - $25,806
487 Added 6.83%
7,619 $316,000
Q1 2024

Apr 19, 2024

SELL
$47.98 - $54.4 $9,931 - $11,260
-207 Reduced 2.82%
7,132 $386,000
Q4 2023

Jan 19, 2024

SELL
$48.48 - $57.85 $13,574 - $16,198
-280 Reduced 3.68%
7,339 $376,000
Q3 2023

Oct 10, 2023

SELL
$57.89 - $64.73 $16,845 - $18,836
-291 Reduced 3.68%
7,619 $442,000
Q2 2023

Jul 17, 2023

SELL
$63.71 - $70.74 $9,110 - $10,115
-143 Reduced 1.78%
7,910 $505,000
Q1 2023

May 09, 2023

BUY
$65.71 - $74.53 $31,277 - $35,476
476 Added 6.28%
8,053 $558,000
Q4 2022

Jan 30, 2023

BUY
$68.48 - $81.09 $27,049 - $32,030
395 Added 5.5%
7,577 $545,000
Q3 2022

Oct 18, 2022

SELL
$0.13 - $76.84 $1 - $768
-10 Reduced 0.14%
7,182 $511,000
Q2 2022

Aug 03, 2022

SELL
$72.62 - $79.98 $4,284 - $4,718
-59 Reduced 0.81%
7,192 $554,000
Q1 2022

May 10, 2022

BUY
$61.48 - $73.72 $5,533 - $6,634
90 Added 1.26%
7,251 $530,000
Q4 2021

Jan 21, 2022

BUY
$53.63 - $62.52 $3,271 - $3,813
61 Added 0.86%
7,161 $446,000
Q3 2021

Oct 28, 2021

BUY
$59.17 - $69.31 $2,425 - $2,841
41 Added 0.58%
7,100 $420,000
Q2 2021

Aug 09, 2021

BUY
$61.91 - $67.42 $3,528 - $3,842
57 Added 0.81%
7,059 $472,000
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $2,076 - $2,335
-35 Reduced 0.5%
7,002 $442,000
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $406,316 - $460,430
7,037 New
7,037 $437,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $106B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cohen Investment Advisors LLC Portfolio

Follow Cohen Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cohen Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cohen Investment Advisors LLC with notifications on news.